Articles tagged with Cancer Patients
Researchers found that cigarette smoking was associated with poor response to cisplatin-based chemotherapy in muscle-invasive bladder cancer patients. Current smokers were also at a higher risk of cancer recurrence compared to former and never smokers, according to the study published in BJU International.
The BRCA Exchange aggregates data on thousands of inherited variants in the BRCA1 and BRCA2 genes to improve cancer prevention, screening, and intervention. The resource includes expert classifications of variants, providing information for clinicians and researchers.
Researchers have determined general population quality of life normative data for 15 individual countries, allowing for regional comparisons and valid QLQ-C30 score interpretation. National differences in quality of life scores were found, with respondents from Austria and the Netherlands reporting higher scores.
A new study published in CANCER found that suicide risk increases significantly in the first year following a cancer diagnosis, with the highest increase seen for pancreatic and lung cancers. The study's authors emphasize the importance of screening for suicide risk and providing social and emotional support to newly diagnosed patients.
A new study finds that genetic testing for breast cancer does not cause excessive anxiety, even with ambiguous results. Researchers surveyed 1,063 women and found that the type of test or result did not significantly impact worry levels.
Researchers are developing a breath test to detect cancer at an early stage by analyzing volatile organic compounds in the breath. The PAN Cancer trial aims to identify patterns of VOCs that could indicate the presence of different types of cancer.
Researchers developed two machine learning models to predict cancer patients' symptoms like depression, anxiety, and sleep disturbance. The models accurately predicted the severity of these symptoms throughout treatment, suggesting a potential improvement in quality of life for cancer patients.
A new study found that patients with stage IV ALK-positive lung cancer have a median overall survival of 6.8 years, significantly higher than the 2 percent five-year survival rate for all NSCLC patients. This optimistic outlook is attributed to targeted therapies and careful surveillance.
Medical University of South Carolina researchers found that advanced glycation end products (AGEs) can hamper response to tamoxifen therapy for ER-positive breast cancer patients. Lifestyle interventions, such as exercise and dietary counseling, may help reduce AGE levels and improve treatment outcomes.
Researchers from KAIST have identified novel pathways involving T immune cell exhaustion in liver cancer patients. The study provides evidence for designing optimal strategies for immune checkpoint blockades and offers a new path for customized medicine.
Researchers found a significant association between cancer development and an elevated risk of heart attack and stroke in the months leading up to the diagnosis. The risk was highest for patients with lung and colorectal cancers and those diagnosed with stage 3 or 4 disease, peaking in the month before diagnosis.
Researchers analyzed US population-based cancer registry data and found a significant increased risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia after chemotherapy for most solid tumors. The risk was highest for certain types of cancer, such as lung, ovary, breast, and testis cancers.
A study by the University of Colorado Anschutz Medical Campus found that Facebook advertising can effectively reach rural communities with information and reminders about cancer screening. The EndCancer initiative resulted in a high engagement rate, with 96% of participants staying enrolled.
Researchers analyzed data from over 1,000 breast cancer patients and identified seven clusters of patients based on their immune evasion mechanisms. This study provides a better understanding of how breast cancer hides from the immune system, allowing oncologists to develop more personalized treatment options.
Researchers created a patient-specific tumor 'organoid' model to identify the most effective treatment for each tumor. The study successfully generated organoids for nine out of 12 patients, demonstrating the potential for personalized medicine.
A new study found that cancer patients, particularly those with blood-related cancers, have a significantly higher risk of developing shingles due to the virus reactivating later in life. New shingles vaccines offer great promise as a strategy to prevent shingles and its complications in cancer patients.
A study at Beth Israel Deaconess Medical Center found that mice infected with H. pylori bacteria and lacking claudin 18 developed precancerous cells and polyps. The loss of claudin 18 alone was enough to prompt precancerous cell development, indicating a new strategy to inhibit gastric cancer progression.
A recent study published in eLife found a strong relationship between copy number changes in genes and cancer patient outcomes. The researchers identified specific biomarkers that can determine a patient's prognosis, providing new hope for personalized cancer treatment.
Scientists identified that loss of two genes drives serrated colorectal cancer and found a combination treatment that has treated the cancer in mice. This discovery holds implications for patient care and may provide insights into the link between inflammatory bowel disease and colorectal cancer.
Researchers at McGill University Health Centre found a gene called EGFRvIII that changes the content of messages exchanged between cells, leading to aggressive brain cancer glioblastoma. This discovery holds promise for developing tests and tailored treatments for patients with glioblastoma.
A novel tool has been developed to identify genetic changes in Lynch syndrome genes associated with disease symptoms. The tool, combining laboratory test results with computer-based modeling and clinical data, achieves an accuracy of about 97 percent, making it suitable for clinical use.
A new study found that an ultrarestrictive opioid prescribing strategy was associated with fewer pills dispensed after surgery, without changes in postoperative pain scores or complications. The protocol reduced opioid pill dispensing by 72-85% for patients undergoing different types of surgery.
The study discovered fractal characteristics in gene expression, enabling the prediction of gene-to-gene interactions. This knowledge can help scientists engineer cells to perform specific tasks, such as drug delivery for cancer treatment.
Scientists at DKFZ developed XRNAX to analyze interactions between all RNA classes with cellular proteins. The new method identifies hundreds of previously unknown protein-RNA bindings and sheds light on diseases including cancer, ALS, and viral infections.
A new study identifies key molecular features that predict clinical outcomes in neuroblastoma patients. The research suggests a molecular classification scheme to select the best treatment for each patient, with tumors lacking telomere maintenance mechanisms considered low-risk and those with these features deemed higher-risk.
HIV-infected patients have a higher risk of developing cancer due to the presence of fewer T-cells in their bodies. Researchers found that exosomes play a key role in supporting cancer growth and spread in these patients, who are 500 times more likely to be diagnosed with Kaposi sarcoma.
The combination of ibrutinib plus rituximab was superior to standard treatment in improving progression-free survival and overall survival for patients with chronic lymphocytic leukemia. The treatment also showed fewer serious side effects compared to the standard FCR regimen.
New research reveals that financial difficulties are a significant strain on cancer patients, with over 20% reporting financial trouble. The study found that employment status and cancer type significantly impact financial well-being.
A Cleveland Clinic-led study found that rivaroxaban significantly reduced venous thromboembolism (VTE) and VTE-related death in outpatient, at-risk cancer patients. The medication effectively prevented blood clots during the treatment period, but risk persisted after treatment was discontinued.
Researchers developed a noninvasive diagnostic imaging method for bladder cancer using machine learning analysis of nanoresolution images from urine samples. The method achieved 94% accuracy in diagnosing bladder cancer compared to cystoscopy, the clinical standard.
A new method for detecting bladder cancer has been developed using atomic force microscopy (AFM), which can accurately identify cancerous cells in urine samples with high sensitivity. The test demonstrates over 90% sensitivity in detecting bladder cancer, compared to 20-80% for current non-invasive diagnostics.
The study found nearly 40% of large B cell lymphoma patients remained in remission beyond 2 years after receiving Yescarta treatment. Patients with refractory disease showed durable responses, giving hope for a cure.
A new study highlights the effectiveness of CAR T-cell therapy in treating diffuse large B cell lymphoma patients. The real-world outcomes show that 81% of patients responded to the therapy with 58% having no detectable cancer after four months.
Patients with a current diagnosis of lung cancer were three times more likely to die in hospital following a PCI procedure. Colon cancer had the greatest association with major bleeding complications post-PCI, with a threefold increase compared to patients with no cancer.
A new smartphone app designed for breast cancer survivors has been shown to help patients achieve significant weight loss and improvements in physical activity. The app, created at Houston Methodist, allows users to interact with their healthcare team and receive real-time feedback and guidance from a clinical dietitian.
Researchers found that it took a year or more from first spotting a symptom to beginning treatment for 10% of patients in England, Northern Ireland, and Wales. The time to diagnosis varied significantly across countries, with Denmark performing the best.
Researchers have discovered that dasatinib sensitizes triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells. Additionally, a systematic review and meta-analysis found an increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy.
Researchers at Johns Hopkins Kimmel Cancer Center found that measuring circulating tumor DNA in blood samples can reveal early stages of cancer growth and spread. The study discovered new treatment options for some patients with melanoma who had mutations not detected by genetic profiling.
The Pancreatic Cancer Collective has awarded $7 million in grants to seven teams of top cancer researchers. The funding will support clinical studies and accelerate the translation of research findings into treatments, with the goal of improving patient outcomes for pancreatic cancer.
A new study confirms that women aged 75 and older should continue receiving mammography screenings due to the significant risk of breast cancer in this age group. The research found a considerable incidence of breast cancer among women over 75, with most cases being invasive and treatable.
A new study found that cessation fatigue, emotional exhaustion and reduced coping resources, increases in the first six weeks of a quit attempt, leading to worse performance on smoking cessation milestones. High cessation fatigue scores predicted lower chances of going a full week without smoking at two months.
A new study published in The Lancet found that standard chemotherapy with cisplatin is more effective than cetuximab in treating HPV-positive throat cancer. Patients who received cisplatin had a significantly higher two-year overall survival rate and lower cancer recurrence rates compared to those on cetuximab.
Researchers have developed a CRISPR-based system called SLICE to rapidly assess gene function in primary immune cells, guiding decision-making for next-generation cell therapies. The new method identified genes that promote T cell replication and suppress it, revealing key regulators of proliferation.
Patients with biliary tract cancer and small intestine adenocarcinoma have responded well to a combination of dabrafenib and trametinib, surviving longer without disease progression. The median overall survival time was 11.3 months, with some patients surviving up to two years.
A phase I trial of a new drug combination using nivolumab and pixatimod has reported clinical benefit in four out of five patients with microsatellite stable colorectal cancer. The combination is thought to overcome intrinsic resistance to PD-1 inhibitors in MSS CRC, suggesting potential benefits for this patient population.
ZW25, an antibody targeting the HER2 receptor, has shown encouraging anti-tumour activity in patients with advanced cancers driven by HER2. The median time patients survived without disease progression was 6.21 months, and 13 experienced tumour shrinkage.
Researchers found fecal microbiota transplantation (FMT) to be an effective treatment for severe colitis caused by immune checkpoint inhibitors. The study showed both patients experienced significant improvements in inflammation and ulcerations after FMT, with reduced resemblance to their own pre-treatment gut microbiome.
Researchers presented a phase 2 trial showing capivasertib's potential in treating various types of cancer with the AKT mutation. The treatment resulted in tumor shrinkage in 23% of patients and prolonged time without tumor growth for 52%.
Researchers have developed a new method that can detect hard-to-trace tumor DNA in the blood by focusing on specific fragment sizes. The technique improves cancer detection and may also be applicable to other types of DNA in body fluids.
A new report by ESTRO highlights the need for improved access to radiotherapy in Europe, citing a quarter of patients who need treatment not receiving it. Experts recommend increased investment, better understanding, and integration into cancer care plans.
Head and neck squamous cell carcinoma patients who receive timely care have better survival rates compared to those with delayed care. MUSC researchers found that African American patients are disproportionately affected by delays in treatment, highlighting the need for coordinated action to address this issue.
A survey of 506 UK health professionals found that 29% would not recommend e-cigarettes to cancer patients who smoke, highlighting the need for clearer guidance and training. The study suggests that e-cigarettes are a substantially less harmful alternative to smoking tobacco for cancer patients.
A prognostic model using machine learning accurately stratifies African-American breast cancer patients into high- and low-risk populations based on protein expression levels. The model identifies a combination of four proteins associated with increased risk of death, suggesting specific therapeutic regimens for this underserved demogr...
An interactive online LGBT cultural competency training program improved oncologists' knowledge and clinical practices on LGBT patients. The program increased correct answers on LGBT-related knowledge items by 52% and favorable perspectives toward LGBT people by 70%.
Researchers discovered a new compound that enhances the efficacy of proteasome inhibitors, commonly used to treat multiple myeloma. The compound targets protein disulfide isomerases, making it effective against drug-resistant cells. This breakthrough offers hope for patients with this cancer.
Researchers found that targeting tumor sites with radiation or surgery after initial treatment can significantly improve overall survival time for patients. Progression-free survival and toxicity data also showed benefits, with median overall survival times of up to 41.2 months.
A team of researchers, led by Dr. El Bachir Affar and Dr. Marc Therrien, has made a groundbreaking discovery about the molecular mechanisms that prevent cancer from developing. They found that protein BAP1 works in tandem with partner ASXL2 to protect cells and keep organs cancer-free.
Researchers identified a link between chromatin, transcription factors, and gene activation patterns in cancer. They found that specific mutations in chromatin can lead to changes in gene activity, driving cancer growth and development. The study provides new insights into cancer biology and potential treatments.
Head and neck cancer survivors are at a higher risk of death by suicide, with the rate being two times that of other cancer survivors and four times that of the general population. The study found that approximately one-half of head and neck cancer survivors become functionally disabled after completing treatment.
Researchers have identified three proteins that regulate each other with surprising complexity, potentially leading to treatments for some forms of infertility and fighting aggressive cancers. The discovery could also inform precision medicine treatments for certain types of aggressive cancers.